Table 1.
Patients’ characteristics of the study population at admission stratified according to the presence of cirrhosis
Parameters | All patients (n = 1068) | Cirrhosis (n = 47) | No cirrhosis (n = 1021) | p value |
---|---|---|---|---|
Age, years median; IQR | 61 (50–72) | 62 (51–67) | 61 (50–72) | 0.92 |
Male, n % | 765 (72) | 35 (74) | 730 (72) | 0.66 |
Weight, kg median; IQR | 80 (70–90) | 80 (69.5–93) | 80 (70–90) | 0.72 |
Height, cm median; IQR | 175 (168–180) | 175 (165–180) | 175 (168–180) | 0.59 |
SOFA admission, pts median; IQR | 9 (6–12) | 11 (7.5–13) | 9 (6–12) | < 0.05 |
SAPS II admission, pts median; IQR | 80 (74–88) | 87 (77.5–100) | 80 (73–87) | < 0.001 |
Charlson comorbidity index, pts. median; IQR | 1 (0–3) | 4 (2.5–6) | 1 (0–2) | < 0.001 |
Cause of arrest, n % | ||||
Cardiac | 678 (63) | 21 (45) | 657 (64) | < 0.05 |
Out of hospital, n % | 798 (75) | 31 (66) | 767 (75) | 0.16 |
Invasive mechanical ventilation, n % | 850 (80) | 35 (74) | 815 (80) | 0.37 |
Before cardiac arrest—normal CPC, n % | 1043 (98) | 45 (96) | 998 (98) | 0.45 |
Before cardiac arrest—normal OPC, n % | 973 (91) | 39 (83) | 934 (91) | 0.09 |
Ischaemic time, min median; IQR* | ||||
No flow | 0 (0–3) | 0 (0–3.5) | 0 (0–3) | 0.49 |
Low flow | 13 (4–25) | 11 (3–23) | 13 (4–25) | 0.51 |
Time to ROSC | 16 (5–30) | 15 (3–27) | 16 (5–30) | 0.42 |
Epinephrine cumulative (mg) median; IQR | 3 (1–4) | 3 (1–5.5) | 3 (1–4) | < 0.001 |
Witnessed cardiac arrest, n % | 921 (86) | 42 (89) | 879 (86) | 0.56 |
Initial rhythm, n % | ||||
VT/VF | 550 (51) | 10 (21) | 540 (53) | < 0.001 |
PEA/asystole | 465 (44) | 35 (75) | 430 (42) | |
Other/unknown | 53 (5) | 2 (4) | 51 (5) | 0.82 |
Defibrillation, n % | 646 (60) | 14 (30) | 632 (62) | < 0.001 |
Therapeutic hypothermia, n % | 666 (62) | 18 (38) | 648 (63) | < 0.001 |
SOFA Sequential Organ Failure Assessment, SAPS Simplified Acute Physiology Score, CPC cerebral performance categories, OPC overall performance categories, ROSC return of spontaneous circulation, VT ventricular tachycardia, VF ventricular fibrillation, PEA pulseless electrical activity
* Overall (n = 926), cirrhosis (n = 41), no cirrhosis (n = 1021)